Background The role of angiotensin-receptor blockers (ARBs) in treating patients with chronic heart failure and high-risk acute myocardial infarction (MI) has been controversial, and recent clinical trials provide more information on this topic.Purpose To quantify the effect of ARBs when compared wi...
No comments yet
Be the first to share your thoughts!